Literature DB >> 31968983

Renal ablation: current management strategies and controversies.

Jim Zhong1, Tze Min Wah2.   

Abstract

Percutaneous image-guided renal ablation provides minimally invasive and safe treatment to small renal cell carcinomas (RCCs) whilst preserving renal function. In addition, it achieves similar oncologic outcomes as surgery. This article aims to outline an overview of the current types of ablative technology, present the current evidence and discuss controversies on image-guided renal ablation.

Entities:  

Keywords:  Radiofrequency ablation (RFA); computed tomography (CT); cryoablation (CRYO); irreversible electroporation (IRE); magnetic resonance imaging (MRI); microwave ablation (MWA); stereotactic ablative radiotherapy (SABR)

Mesh:

Year:  2019        PMID: 31968983     DOI: 10.21037/cco.2019.12.08

Source DB:  PubMed          Journal:  Chin Clin Oncol        ISSN: 2304-3865


  3 in total

Review 1.  Image-Guided Percutaneous Ablation for Primary and Metastatic Tumors.

Authors:  Arian Mansur; Tushar Garg; Apurva Shrigiriwar; Vahid Etezadi; Christos Georgiades; Peiman Habibollahi; Timothy C Huber; Juan C Camacho; Sherif G Nour; Alan Alper Sag; John David Prologo; Nariman Nezami
Journal:  Diagnostics (Basel)       Date:  2022-05-24

2.  The impact of insurance status on the survival outcomes of patients with renal cell carcinoma.

Authors:  Yan Li; Ming-Xi Zhu; Bing Zhang
Journal:  Transl Androl Urol       Date:  2020-08

3.  Vitexin suppresses renal cell carcinoma by regulating mTOR pathways.

Authors:  Yuhong Li; Qinghai Sun; Hui Li; Bin Yang; Meng Wang
Journal:  Transl Androl Urol       Date:  2020-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.